Dark

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR

Market Open

May 15, 2025 3:56:30 PM EDT

2.85USD0.000%(0.00)2,089

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 12, 2025 8:00:30 AM EDT

2.58USD-9.474%(-0.27)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

2.68M

Headquarters

Po Box 4143 14 Einstein Street, Ness Ziona, Israel

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Last Split

May 21, 20241for10reverse

SCNI Stats

Avg. Vol. 10 Day

6,658

Avg. Vol. 30 Day

19,822

Market Cap

2,679,005

Shares Out.

933,679

On/Off Exchange

25%/75%

6 Month Beta

0.27

1 Year Beta

0.58

2 Year Beta

0.72

52 Week Low

1.90

52 Week High

8.92

SMA50

2.77

SMA200

3.36

1 Week

+11.21%

1 Month

+49.44%

3 Month

-13.28%

6 Month

+0.68%

1 Year

-36.24%

2 Year

-78.18%

Profile

biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax's technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.

SCNI Stock Summary

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) stock price today is $2.85, and today's volume is 2,089. SCNI is down 0.000% today. The 30 day average volume is 19,822. SCNI market cap is 2.68M with 933,679 shares outstanding.

.dark-mode .ppp3qk{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ppp3qk{ color: #333333; background-color: white; border: 2px solid #333333; }SCNIScinai Immunotherapeutics Ltd.stock NASDAQ ADR

SCNI Stock Summary

SCNI
Scinai Immunotherapeutics Ltd.
stock NASDAQ ADR